Ketamine for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Jun 2025: Trial registered, NCT07009158
  2. 31 Mar 2026: Trial started, NCT07009158

The trials

NCT07009158: Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

State
Under way
Phase
Phase 1 and Phase 2
People
30 planned
Started
31 Mar 2026
Primary completion
Sep 2029
Arms
KAP group
Results
None posted
  1. 6 Jun 2025: Trial registered
  2. 31 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as 0.2 mg/kg ketamine, 1st perfusion of ketamine, 2nd perfusion of ketamine, Anaket v, Calypsol, CLORKETAM 1000, IMALGENE 1000, Intranasal Ketamine (IN), Intranasal ketamine, Ketafol component ketamine, KETASOL 100, Ketamine Infusion, Narketan, Tekam, Ursotamin, Vetaket.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.